Some doctors, psychologists, and eating disorder experts worry the new weight loss medications, originally developed to treat diabetes, could become a problem long-term. Most people are likely to regain lost weight if they don’t keep taking the drugs for life, and the psychological toll of that rebound could be damaging, psychologists predict. Even weight loss companies like Jenny Craig wonder if the drugs could be bad or good for business.

About two-thirds of HR people from organizations that offered wellness initiatives indicated these efforts were “somewhat effective” or “very effective” in reducing healthcare costs. The return on investment (ROI) related to employee wellness programs typically includes the overall healthcare cost-savings achieved and productivity increases due to reduced sick days employees take.

The FDA has approved an Alzheimer’s drug that slowed the rate of cognitive decline in clinical trials without using an advisory committee. The high drug cost — priced at $26,000 per year, Eisai said — combined with strict restrictions on reimbursement by US government-funded health schemes will severely limit the number of patients able to access the medicine, at least for now. What is going on here?